Stellar Biotechnologies Inc (TSXV: KLH), a junior biotechnology company, experienced a strong upward share price momentum after gaining more than 16% during each of the past two consecutive trading days with significant number of shares exchanging hands. In the last trading session, KLH was the top gainer in the Canadian healthcare sector after climbing 21.2% and closed Friday at C$1.03 while recording huge volumes of 436,267 shares. Last week, KLH was also the top weekly gainer in the sector after rallying 41% with 5-day average trading volumes of 248,514 shares, while the stock accumulated over 10% during the past one month with daily average trading volumes of 153,907 shares.
Company Description:
Stellar Biotechnologies Inc (TSXV: KLH) is a biotechnology company. The company produces components of therapeutic vaccines used to treat cancer, hypertension, arthritis, drug addiction and other serious chronic diseases.
1-Year Stock Chart:
Source: Bloomberg
